Posts Tagged 'allergan'

Three New Deaths Attributed to Cancer Tied to Breast Implants

new deaths reported from rare breast implant associated breast cancerThe death toll formally attributed to breast implant-associated anaplastic large cell lymphoma now stands at 36, although it could be higher. Three new fatalities have occurred within the same six months and just weeks before the implants implicated in the deaths were set to be recalled.

The implants in question were made by Allergan prior to its acquisition by AbbVie. The Biocell textured breast ...

continue reading...

Lawsuit Alleges Textured Breast Implant Cancer Risk Coverup at Allergan

Allergan facing US lawsuits over textured breast implantsMuch of the initial concern over textured breast implant associated cases of anaplastic large cell lymphoma started out focused on non-U.S. markets. While the vast majority of U.S.-based breast implant procedures utilize smooth implants, the opposite held true for much of the rest of the market.

Six U.S. women who had textured breast implants used in their augmentation procedures have sued Allergan over their increased cancer risk and allege that ...

continue reading...

Breast Implant Cancer Cases Will Go to Multidistrict Litigation

Allergan breast implant cases set for multi district litigationApproximately 30 lawsuits filed against healthcare goods manufacturer Allergan will be consolidated into a single multidistrict litigation. Plaintiffs in the lawsuits made the request to the Judicial Panel on Multidistrict Litigation over their claims that the company’s breast implant products are responsible for their development or potential development of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.

The extraordinarily rare cancer first became evident ...

continue reading...

As Women Call for Action, FDA Continues “Assessment” of Breast Implant Cancer Risk

FDA continues assessment of breast implant cancer riskA growing number of women are being diagnosed with a form of breast cancer linked to breast implants, and the calls for lawsuits and legislative action or regulation are rising.

16 deaths may already be associated with the condition known as BIA-ALCL or breast-implant associated anaplastic large cell lymphoma. U.S. diagnoses of the cancer are now up to 457 from a previous high of 414. Over ...

continue reading...

IBS-D Drug Could Threaten Patient Safety after Single Day’s Use

viberzi dangerous after one dayFor those who suffer from irritable bowel syndrome with diarrhea, or IBS-D, the trouble is two-fold. Physically, they endure severe abdominal pain and possible nausea on a regular basis, as well as excessive amounts of gas and sudden urges to reach the nearest bathroom. But they also face potential embarrassment over their condition and can suffer anxiety and loss of appetite. These social aspects can have dramatic impacts on their quality of ...

continue reading...

IBS-D Drug Could Kill Those Without Gallbladder

viberzi may cause fatal pancreatitis in patients with no gallbladderMay 27, 2015 was a busy day at the FDA and a good day for two competing pharmaceutical companies. Allergan’s Viberzi, as well as Valeant’s Xifaxan medications were both approved by the agency to treat IBS-D, or irritable bowel syndrome with diarrhea.

Patients suffering from irritable bowel syndrome must contend with frequent agonizing bouts of lower stomach distress. The pain can be intense and is amplified by the ...

continue reading...